• Measles Is Endemic in the U.S. Again: What Losing Elimination Status Means for You
    Nov 18 2026

    On Nov. 17 the Pan American Health Organization announced that measles transmission has been re-established in the United States, Mexico and Bolivia, ending U.S. elimination status held since 2000; the U.S. chain of transmission began in January 2025, the U.S. has reported more than 5,000 cases this year, and the Americas have had 58,213 confirmed cases and 82 deaths, versus 12,806 cases at this point last year. We cover what it takes to regain the status (Brazil did it in 2024), the cost of U.S. outbreaks (Johns Hopkins estimates via KFF Health News), and PAHO's advice on checking for two MMR doses. Plus: a Lancet Psychiatry network meta-analysis from Radboud University Medical Center (115 randomized trials, 30,000+ people) finding escitalopram, duloxetine and agomelatine beat fluoxetine at keeping people well long term; a Science review (University of Gothenburg and University of Copenhagen) on GLP-1 drugs and cognition, including the negative EVOKE Alzheimer's trials; a Lancet Digital Health study (City St George's and UCL, 27,382 patients) where AI-measured ejection fraction on heart MRI predicted survival slightly better than clinicians, in 2–3 seconds per scan; and a UC Merced study (Journal of Studies on Alcohol and Drugs, 415,000+ adults) linking cannabis use disorder to 57% higher odds of suicidal thoughts, a link that did not grow as legalization spread (988 Suicide and Crisis Lifeline). Quick hits on an early, H1N1-heavy flu season (CDC FluView), a Jackson Laboratory mouse study on where the heart ages, two new FDA Salmonella investigations, and a University of Waterloo model of vitamin C and nitrites. And one small idea from a UTHealth Houston iScience study of 87 adults: try eating and going to bed a little earlier. This show is for understanding the news, not medical advice.

    Music by Cheerry Red

    Show More Show Less
    14 mins
  • Special: Turkey Tail and Agarikon Mushrooms and Your Immune System: What the Research Really Shows
    Nov 17 2026

    A special episode on two mushrooms and the immune system, sorting human, animal and lab evidence. Turkey tail (Trametes/Coriolus versicolor): its extract PSK (Krestin) is used as a cancer adjunct in Japan, and per the National Cancer Institute's PDQ summary a meta-analysis of 8 randomized trials (8,009 stomach cancer patients) tied PSK plus chemotherapy to a lower risk of death (HR 0.88), with colorectal and lung data too; but many trials are decades old, some weren't randomized, and store supplements aren't the prescription extract. A 2012 University of Minnesota phase 1 trial (NIH-funded; 9 women with breast cancer, 3–9 g/day) found it well tolerated with trends in immune cell counts. We cover the gut microbiome trial (24 volunteers), the HPV vaginal gel studies and the 2026 FIGO/IGCS statement that does not endorse topical HPV treatments, and the Penn Vet dog studies (15 dogs, then 101 dogs where PSP added to chemo did not help). Agarikon (Fomitopsis/Laricifomes officinalis): an endangered old-growth fungus whose evidence is mostly lab work (pox-related viruses in a U.S. biodefense screen, flu strains, tuberculosis-active compounds), plus a 2026 UC San Diego trial in BMC Immunology (90 adults) of an agarikon–turkey tail mycelium blend with COVID-19 vaccination, with capsules supplied by Fungi Perfecti. Safety: Memorial Sloan Kettering's notes on side effects, pregnancy and drug interactions; cautions for chemotherapy, immunosuppressants, autoimmune disease and immunotherapy; and how to read a label (fruiting body vs. mycelium on grain, measured beta-glucan). This show is for understanding the news, not medical advice. Talk to your doctor before taking any supplement.

    Music by Cheerry Red

    Show More Show Less
    14 mins
  • Colon Cancer Is Rising Again in Nearly Every Adult Age Group: What the New Data Show
    Nov 16 2026

    After falling for two decades, the U.S. colorectal cancer rate rose in 2023 for the first time in more than 20 years, from 36.7 to 38.3 cases per 100,000 (National Cancer Institute data; NEJM Evidence; lead author Caitlin Murphy, University of Chicago, with UCLA, Emory and UC San Diego). Rates in people 45–49 rose about 12.8% a year from 2019 to 2023, partly because screening now starts at 45, but rates are also rising in every age group through 65–69, which screening can't explain; the researchers point to a birth cohort effect, and the cause is still unknown. We explain the caveats and the screening options. Plus: a Nature study of 844,108 adults testing a new obesity framework that pairs BMI with waist measures and separates clinical from preclinical obesity (senior author Francesco Rubino, King's College London); the FLOWPROMOTE trial (JAMA Cardiology, Aarhus University, 104 patients), where rosuvastatin plus ezetimibe cut LDL 65% and shrank coronary plaque about 21%, versus 38% and about 14% with atorvastatin alone; Johns Hopkins research (NeuroImage: Reports) finding that the entorhinal cortex and amygdala shrink before the hippocampus in early Alzheimer's, and a Stanford Medicine brain-activity score (Science Advances) tied to faster decline; and the SUPER-Knee trial (Annals of Internal Medicine, La Trobe University, 184 adults), where supervised exercise one to three years after ACL surgery eased pain without harming cartilage. Quick hits on the Great American Smokeout this Thursday, a fiber blend for IBS (Edith Cowan University; two researchers helped create the product), and a mouse study suggesting viral infections can scar the spleen and vaccines may prevent it (Pompeu Fabra University). And one small idea: pick one anchor in your daily routine. This show is for understanding the news, not medical advice.

    Music by Cheerry Red

    Show More Show Less
    14 mins
  • Two Forever Chemicals Linked to an Aggressive Breast Cancer: What the NIH Study Found
    Nov 13 2026

    In an NIH analysis of the Sister Study (more than 50,000 women aged 35–74, each with a sister who had breast cancer; Journal of Clinical Oncology; lead author Che-Jung Chang, senior author Alexandra White), women with the highest blood levels of PFOA had a 67% higher rate of estrogen receptor-negative breast cancer than those with the lowest, and for PFOS the rate was 93% higher. Neither chemical was clearly linked to breast cancer overall, the findings show a link, not proof, and both chemicals have largely been phased out, though most people still carry some. Plus: a Semmelweis University meta-analysis of 24 studies (Sports Medicine – Open) found bone-building blood markers rose up to about 45% with recreational soccer and handball, but much less with walking or jogging and not significantly with standard weight training; a small UCLA trial of oxaloacetate for brain fog in 16 breast cancer survivors (JCO Oncology Advances; no placebo group); a University of Eastern Finland study of 2,546 men linking plant protein to slightly higher testosterone and animal protein to slightly lower; and, ahead of World Diabetes Day, a Pennington Biomedical study (Nature Communications) of Miro1, a muscle protein tied to insulin resistance that fell with aerobic exercise. Quick hits: an update on the federal hemp THC rules (Minnesota's Office of Cannabis Management lists Dec. 11 as the date the federal hemp definition changes), gut bacteria that eat the gut's mucus lining when fiber runs out (Princeton/Ludwig, mice), a gut-to-brain dopamine signal that teaches us to like flavors (UCSF, Nature), and a lab model suggesting Alzheimer's genes can disrupt nerve-to-muscle signals (University of Central Florida). And for the weekend, one small idea: add a little play. This show is for understanding the news, not medical advice.

    Music by Cheerry Red

    Show More Show Less
    14 mins
  • A Weight-Loss Shot Cut Knee Arthritis Pain in Half for Many: What the New Trials Show
    Nov 12 2026

    In two phase 3 trials with just over 1,000 people with painful knee osteoarthritis and excess weight, presented at the American College of Rheumatology meeting and published in the New England Journal of Medicine (lead author Thomas Schnitzer, Northwestern), Eli Lilly's experimental weekly shot retatrutide cut knee pain by about 4 points on a 10-point scale versus about 2 on placebo, and about two-thirds of people on the drug saw their pain cut at least in half, versus 38% on placebo. People lost roughly a fifth to a quarter of their body weight, depending on dose. The trials were Lilly-funded, the drug isn't FDA-approved, and weight loss likely explains most of the benefit. Plus: in 4,523 Americans with dementia (Columbia Mailman and NYU, Journal of Alzheimer's Disease), being overweight or obese at diagnosis was linked to a 16–27% lower risk of death; a Seoul National University study of 71,264 Korean women (European Journal of Nutrition) linked high-sugar foods more than twice a week to 28% higher breast cancer risk, while fruit wasn't linked; a University of Wisconsin–Madison review of 350+ studies on eating less protein, and a 62-person trial in which a low-fat vegan diet cut protein and weight; and a George Institute model (Nature Health) estimating that potassium-enriched salt could prevent close to 3 million deaths a year, with an important warning for people with kidney disease or on certain heart and blood pressure drugs. Quick hits on why heart attacks happen when LDL is low (Chalmers, European Heart Journal), pantethine and psoriasis, acorns, mice and Lyme disease (Cary Institute, PNAS), and a lab test of an anti-HPV chewing gum (Penn Dental Medicine). And for World Pneumonia Day, one five-minute question to ask. This show is for understanding the news, not medical advice.

    Music by Cheerry Red

    Show More Show Less
    14 mins
  • New FDA Eye Warning for Ozempic, Zepbound and Every GLP-1: What to Watch For
    Nov 11 2026

    On November 9, the FDA ordered new warnings for every GLP-1 drug, including Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Trulicity, Victoza and the daily pill orforglipron, about NAION, a rare "stroke in the eye" that can cause sudden, painless vision loss. Across 126 trials with more than 134,000 patients, the rate was about 6.4 cases per 100,000 people per year on GLP-1s versus 3.8 on comparison treatments, just 15 probable cases in all, and the FDA calls it a potential risk, not a proven one. We explain the warning signs and why you shouldn't stop your medication on your own. Plus: for Veterans Day, a national survey of 2,636 veterans from the VA's National Center for PTSD and Yale (Journal of Clinical Psychiatry) found lifetime PTSD at 14.4%, up from 8–9.4% in earlier waves; Eli Lilly's orforglipron cut sleep apnea breathing interruptions by about 18 an hour versus about 5 on placebo in 712 adults (JAMA, Lilly-funded); the OPTIMAL-DIABETES trial of 9,476 adults found a top blood pressure target below 120 didn't significantly cut heart events but raised kidney events (NEJM); a Neurology study of 352 Swedish women linked longer estrogen exposure to healthier brain blood vessels; and new American Academy of Sleep Medicine guidelines for shift work disorder, which affects about 27% of shift workers. Quick hits on 5,182 U.S. measles cases and the review of elimination status, Mayo Clinic's experimental pancreatic cancer vaccine, and a closed alfalfa sprout outbreak and new sprout recalls. This show is for understanding the news, not medical advice.

    Music by Cheerry Red

    Show More Show Less
    14 mins
  • The Federal Ban on THC and CBD Gummies Starts This Week: What It Means for You
    Nov 10 2026

    As CNN's Amanda Schupak and Sarah Owermohle report, a new federal definition of hemp will take many THC and CBD gummies, tinctures and drinks off the market. It lands in two steps: on November 12, lab-made cannabinoids like THC-O, and most delta-8, lose legal hemp status; on December 11, finished products are capped at 0.4 milligrams of total THC per container, which effectively bans full-spectrum edibles. We explain what to check on the label and what to do if you use these products for sleep or anxiety. Plus: in the OPTIMAL-STROKE trial of 4,368 stroke survivors (New England Journal of Medicine), aiming for a top blood pressure number below 120 cut major cardiovascular events about 21%, with more kidney problems; the REDUCE trial found spironolactone lowered home blood pressure almost 8 points after stroke; an AI reading Apple Watch and Galaxy Watch ECGs may help flag weak heart pumping, in a preliminary AHA abstract; a University of Hong Kong study of 120,000+ older adults linked bisphosphonate bone drugs to 16–24% lower dementia risk; and an analysis of 26,000+ men in The Lancet Healthy Longevity tied very low testosterone to an 18% higher risk of dying from cancer. Quick hits on the ziltivekimab heart trial flop, the Once Upon a Farm Tractor Wheels toddler bar recall, and an early, fast-rising flu season (1.7 million illnesses so far). This show is for understanding the news, not medical advice.

    Music by Cheerry Red

    Show More Show Less
    14 mins
  • A Flu Shot and a Cup of Coffee: Two Simple Habits Tied to a Healthier Brain
    Nov 9 2026

    A UTHealth Houston study of nearly 200,000 adults 65 and older, published in Neurology, found that the standard flu shot was linked to about a 40% lower risk of Alzheimer's, and the high-dose shot to a risk nearly 55% lower. We explain what that might mean and who should ask about the high-dose shot. Plus: a JAMA study following U.S. adults for up to 43 years links 2–3 cups of caffeinated coffee a day to lower dementia risk, but not decaf; as CNN's Brenda Goodman reports, Novartis's pelacarsen cut Lp(a) by 77% in more than 8,300 people but didn't prevent heart attacks or strokes; a trial in adults 70 and older finds stopping statins was generally safe at two years, with a small rise in risk by four; FDA reports tie energy drinks to cardiac arrest and heart rhythm problems in young adults; an irregular sleep schedule was linked to a 20–23% higher risk of serious heart events; and a small University of Toronto study on full-fat dairy. Quick hits on three measles deaths in a week and a gel that rebuilt tooth enamel in the lab. This show is for understanding the news, not medical advice.


    Music by Cheerry Red

    Hosted on Acast. See acast.com/privacy for more information.

    Show More Show Less
    14 mins